Oral vs IV corticosteroids for in-hospital treatment of COPD exacerbations

Chest

Volumn 132, Issue 6, 2007, Pages 1728-1729

  Tashkin, Donald P ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRONCHODILATING AGENT; CORTICOSTEROID; METHYLPREDNISOLONE; PREDNISOLONE; PREDNISONE;

ARTIFICIAL VENTILATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE COURSE; DISEASE EXACERBATION; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFICACY; EDITORIAL; FORCED EXPIRATORY VOLUME; HOSPITAL PATIENT; HUMAN; HYPERGLYCEMIA; INTENSIVE CARE UNIT; MORTALITY; PRIORITY JOURNAL; TREATMENT FAILURE;

EID: 37549023465     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.07-1622     Document Type: Editorial

References (12)

1. Global initiative for chronic obstructive pulmonary disease. Global strategy for the diagnosis, management and prevention of COPD 2006. Available at: www.goldcopd.org/Guideline item. Accessed January 22, 2007
2. Parker CM, Voduc N, Aaron SC, et al. Physiological changes during symptom recovery from moderate exacerbations of COPD. Eur Respir J 2005; 26:376-378
3. Spencer S, Jones PW, GLOBE Study Group. Time course of recovery of health status following an infective exacerbation of chronic bronchitis. Thorax 2003; 58:589-593
4. Donaldson GC, Seemungal TA, Bhowmik A, et al. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 2002;57:847-852
5. Celli BR, Barnes PJ. Exacerbations of chronic obstructive pulmonary disease. Eur Respir J 2007; 29:1224-1238
6. Gunen H, Hacievliyagil SS, Kosar F, et al. Factors affecting survival of hospitalized patients with COPD. Eur Respir J 2005; 26:234-241
7. Ai-Ping C, Lee K-H, Lim T-K. In-hospital and 5-year mortality of patients treated in the ICU for acute exacerbation of COPD: a retrospective study. Chest 2005; 128:518-524
8. Wouters EF. Economic analysis of the Confronting COPD survey: an overview of results. Respir Med 2003; 97(Suppl C):S3-S14
9. Sin DD, McAlister FA, Man SFP, et al. Contemporary management of chronic obstructive pulmonary disease: scientific review. JAMA 2003; 290:2301-2312
10. Niewoehner DE, Erbland MC, Deupree RH, et al. Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. N Engl J Med 1999; 340:1941-1947
11. Davies L, Angus RM, Calverley PMA. Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomized controlled trial. Lancet 1999; 354:456-460
12. de Jong YP, Uil SM, Grotjohan HP, et al. Oral or intravenous prednisolone in the treatment of COPD exacerbations: a randomized controlled, double-blind study. Chest 2007; 132:1741-1747